Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02870374
Other study ID # 2012-15
Secondary ID 2012-A00634-39
Status Active, not recruiting
Phase N/A
First received August 12, 2016
Last updated August 12, 2016
Start date January 2012
Est. completion date January 2017

Study information

Verified date August 2016
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertés
Study type Observational

Clinical Trial Summary

The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.

The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 2000
Est. completion date January 2017
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient with a transplant kidney

Exclusion Criteria:

- Patient not able to answer survey

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Behavioral:
Answering specific quality of life questionnaire in kidneys transplantation population


Locations

Country Name City State
France Assistance Publique Hôpitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of change in quality of life in kidneys transplantation patients using ReTransQol 1 year No